arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


Disclaimer: CME certification for these activities has expired. All information is pertinent to the timeframe in which it was released.


Podcasts - Perspectives in Central Nervous System Malignancies


Goal
To provide neuro-oncologists and radiation oncologists with up-to-date information regarding the diagnosis, management, and treatment of patients with CNS malignancies.

Target Audience
Neuro-oncologists and radiation oncologists.

Learning Objectives
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

After completing the module, the participant should be able to:

  • Discuss the latest trends in diagnosing central nervous system (CNS) malignancies.
  • Identify how various factors affect the prognosis of CNS malignancies.
  • Evaluate novel treatment strategies and emerging agents for the management of gliomas.
  • Differentiate among and apply the least invasive techniques for re-irradiation of gliomas.
  • Describe the heterogeneity within tumor types and the key factors to consider when developing treatment plans tailored to individual patients.
  • Incorporate information and conclusions from recent clinical trials into daily clinical practice, especially the management of gliomas.

Full Disclosure Policy Affecting CME Activities: As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Directors reported the following:

Martin J. van den Bent, MD, PhD
Professor, Department of Neurology
Erasmus University Medical Center
Rotterdam, The Netherlands
Dr van den Bent reports receiving grants/research support from Novartis; serving as a consultant for Adnexus, Novartis, and Schering-Plough; and serving on the speakers’ bureau for Schering-Plough.

W. K. Alfred Yung, MD
Professor—NeuroOncology
MD Anderson Cancer Center
Houston, Texas
Dr Yung reports receiving grants/research support from Genentech, Inc, Novartis, and Schering-Plough; serving as a consultant for/receiving honoraria from Myriad, Novartis, and Schering-Plough; and serving on the speakers’ bureau for Schering-Plough.

Stuart A. Grossman, MD
Professor, Oncology, Medicine, and Neurosurgery
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Dr Grossman reports having no significant financial or advisory relationships with corporate organizations related to this activity.

In the following 4 podcasts, Martin J. van den Bent, MD, PhD, of Erasmus University Medical Center, and W. K. Alfred Yung, MD, of MD Anderson Cancer Center, provide additional insights into the content of the PCNSM4: Perspectives in Central Nervous System Malignancies conference, which they chaired. This meeting, which was held March 28-29, 2008, in Berlin, Germany, covered a variety of topics, including the latest trends in diagnosis and prognosis for central nervous system (CNS) malignancies, novel treatment strategies for the management of gliomas, and controversies associated with the management of some CNS malignancies. Each podcast is moderated by Stuart A. Grossman, MD, from The Johns Hopkins University School of Medicine, who participated in the meeting and serves as a Course Director of this program with Dr. van den Bent and Dr. Yung.  After listening to the podcasts, participants may receive credit by completing the CME test, evaluation, and receiving a score of 70% or higher.





Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334), is published by Galen Publishing, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2012 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of The Healthcare Media Group, LLC.